These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23021229)

  • 1. [Triamcinolone acetonide without solvents].
    Martínez Rubio M; Moya Moya M; Selva Otaola-Urruchi J; Martínez Lazcano T; Belmonte Martínez J
    Arch Soc Esp Oftalmol; 2012 Oct; 87(10):320-3. PubMed ID: 23021229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of different techniques for purification of triamcinolone acetonide suspension for intravitreal use.
    García-Arumí J; Boixadera A; Giralt J; Martinez-Castillo V; Gomez-Ulla F; Corcostegui B; García-Arumí E
    Br J Ophthalmol; 2005 Sep; 89(9):1112-4. PubMed ID: 16113361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple and rapid method for purification of triamcinolone acetonide suspension for intravitreal injection.
    Hernaez-Ortega MC; Soto-Pedre E
    Ophthalmic Surg Lasers Imaging; 2004; 35(4):350-1. PubMed ID: 15305565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triamcinolone acetonide concentration after filtration of the solvent agent.
    Spandau UH; Derse M; Schmitz-Valckenberg P; Papoulis C; Sagstetter BU; Stiefvater K; Jonas JB
    Am J Ophthalmol; 2005 Apr; 139(4):712-3. PubMed ID: 15808171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of different preparation methods for a preservative free triamcinolone acetonide preparation for intravitreal administration: a validated stability indicating HPLC-method.
    Korodi T; Lachmann B; Kopelent-Frank H
    Pharmazie; 2010 Dec; 65(12):860-6. PubMed ID: 21284253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolating triamcinolone acetonide particles for intravitreal use with a porous membrane filter.
    Nishimura A; Kobayashi A; Segawa Y; Sakurai M; Shirao E; Shirao Y; Sugiyama K
    Retina; 2003 Dec; 23(6):777-9. PubMed ID: 14707826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of purification methods and development of intravitreal injection of triamcinolone acetonide.
    Oishi M; Maeda S; Nakamura A; Kurokawa N; Ohguro N; Tano Y
    Jpn J Ophthalmol; 2005; 49(5):384-7. PubMed ID: 16187038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of benzyl alcohol from a commercially available triamcinolone acetonide suspension for intravitreal use.
    Hernaez-Ortega MC; Soto-Pedre E
    Ophthalmic Surg Lasers Imaging; 2006; 37(2):162-4. PubMed ID: 16583642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of triamcinolone acetonide solutions as determined by high-performance liquid chromatography.
    Gupta VD
    J Pharm Sci; 1983 Dec; 72(12):1453-6. PubMed ID: 6663485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of sedimented triamcinolone for intravitreal injection.
    Tsong JW; Persaud TO; Mansour SE
    Retina; 2007; 27(9):1255-9. PubMed ID: 18046234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased incidence of sterile endophthalmitis after intravitreal triamcinolone acetonide in spring 2006.
    Stepien KE; Eaton AM; Jaffe GJ; Davis JL; Raja J; Feuer W
    Retina; 2009 Feb; 29(2):207-13. PubMed ID: 19050670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal triamcinolone acetonide concentration after subtenon injection.
    Thomas ER; Wang J; Ege E; Madsen R; Hainsworth DP
    Am J Ophthalmol; 2006 Nov; 142(5):860-1. PubMed ID: 17056371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advantages of pentafluorophenylpropyl stationary phase over conventional C18 stationary phase--application to analysis of triamcinolone acetonide.
    Havlíková L; Matysová L; Hájková R; Satínský D; Solich P
    Talanta; 2008 Jul; 76(3):597-601. PubMed ID: 18585326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of physicochemical properties and degradation kinetics of triamcinolone acetonide palmitate in vitro.
    Peng C; Liu C; Tang X
    Drug Dev Ind Pharm; 2010 Dec; 36(12):1469-76. PubMed ID: 20524902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of triamcinolone acetonide and hydrocortisone in human plasma by high-performance liquid chromatography.
    Döppenschmitt SA; Scheidel B; Harrison F; Surmann JP
    J Chromatogr B Biomed Appl; 1996 Jun; 682(1):79-88. PubMed ID: 8832428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservative-free triamcinolone acetonide suspension developed for intravitreal injection.
    Bitter C; Suter K; Figueiredo V; Pruente C; Hatz K; Surber C
    J Ocul Pharmacol Ther; 2008 Feb; 24(1):62-9. PubMed ID: 18370876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Triamcinolone Acetonide Reference Standard (Control 981) of National Institute of Health Sciences].
    Iwata M; Maekawa K; Saito H; Tanimoto T; Okada S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1999; (117):208-10. PubMed ID: 10859949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further characterization of ocular safety profile of commercially available preserved and preservative-free triamcinolone acetonide.
    Li Y; Chen H; Hou J; Zhang Y; Li G; Gu X; Luo L; Shen H; Qu J; Cheng L
    Retina; 2012 Feb; 32(2):364-74. PubMed ID: 21909054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of triamcinolone acetonide after intravitreal injection.
    Degenring RF; Jonas JB
    Am J Ophthalmol; 2004 Jun; 137(6):1142-3. PubMed ID: 15183810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular availability of triamcinolone acetonide after intravitreal injection.
    Jonas JB
    Am J Ophthalmol; 2004 Mar; 137(3):560-2. PubMed ID: 15013884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.